HULIO

This brand name is authorized in Austria, Germany, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania

Active ingredients

The drug HULIO contains one active pharmaceutical ingredient (API):

1 Adalimumab UNII FYS6T7F842 - ADALIMUMAB

Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM). Read about Adalimumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AB04	Adalimumab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 14338613, 14338642, 14338719, 14338725, 14338754, 15391673, 15391696, 15391710, 15391727, 15395613, 15395636, 15395642, 15395659, 15530034, 15530040, 15530057, 15530063, 15617137, 15617143, 15617166, 15617172, 15629695, 15629703, 15637051, 15637068, 15637074, 15637080, 15639357, 15639386, 15659070, 15659087, 15817675, 15817681, 15862960, 15862977, 15863008, 15863014, 16011425, 16013878, 16013967, 16013973, 16022802, 16022819, 16022825, 16022831, 16702299, 16702307, 16759483, 16759508, 16759514, 16759520, 16759603, 16801392, 16801423, 16868611, 17147368, 17147374, 17231672, 17312531, 17848409, 17904639, 17904645
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 176-MBE-0221
Country: EE	Ravimiamet	Identifier(s): 1780141, 1780152, 1780163, 1780174, 1780185, 1780196, 1780208, 1836266, 1836277
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181319002, 1181319005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 096122, 145866, 399119, 479515
Country: FR	Base de données publique des médicaments	Identifier(s): 62042376, 63895021, 68311292
Country: IE	Health Products Regulatory Authority	Identifier(s): 88938, 88955, 88956
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9095, 9096
Country: IT	Agenzia del Farmaco	Identifier(s): 047088012, 047088024, 047088036, 047088048, 047088051, 047088063, 047088075, 047088087, 047088099, 047088101, 047088113, 047088125, 047088137, 047088149, 047088152, 047088164, 047088176, 047088188, 047088190, 047088202
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086227, 1086228, 1086229, 1086230, 1086231, 1086232, 1086233, 1087057, 1092695, 1092696, 1093477, 1093478, 1093479, 1093480, 1093481, 1093482, 1093483, 1093484, 1093485, 1093486
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106348, 84492
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100409708, 100467435
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64885001, W64886001, W64886002, W64886003, W64887001, W64887002, W64887003